Horizon Investments’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.45M Buy
46,123
+9,145
+25% +$938K 0.05% 309
2025
Q4
$3.92M Sell
36,978
-18,790
-34% -$2.18M 0.05% 304
2025
Q3
$7.07M Buy
55,768
+6,336
+13% +$754K 0.09% 183
2025
Q2
$6.05M Buy
49,432
+49,409
+214,822% +$5.64M 0.1% 171
2025
Q1
$2.33K Hold
23
﹤0.01% 715
2024
Q4
$2.12K Hold
23
﹤0.01% 724
2024
Q3
$2.22K Buy
23
+6
+35% +$539 ﹤0.01% 701
2024
Q2
$1.46K Hold
17
﹤0.01% 713
2024
Q1
$1.4K Buy
17
+11
+183% +$806 ﹤0.01% 704
2023
Q4
$400 Buy
6
+3
+100% +$194 ﹤0.01% 762
2023
Q3
$201 Hold
3
﹤0.01% 789
2023
Q2
$203 Buy
+3
New +$188 ﹤0.01% 764

Other funds holding EHC

Horizon Investments's EHC Position: Q1 2026 in Review

Horizon Investments increased its Encompass Health (EHC) stake by 25% in Q1 2026, buying an estimated $938K and bringing the position to 46,123 shares worth $4.45M. The position accounts for 0.05% of the portfolio, ranked #309.

Horizon Investments first reported a position in EHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $7.07M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Horizon Investments held 46,123 shares of Encompass Health worth $4.45M as of Q1 2026.
  • Horizon Investments bought 9,145 Encompass Health shares in Q1 2026, an estimated $938K.
  • Encompass Health made up 0.05% of Horizon Investments's portfolio in Q1 2026, its #309 holding.
  • Horizon Investments first reported a position in Encompass Health in Q2 2023 and has held it in 12 quarters since.
  • Horizon Investments's Encompass Health position peaked at $7.07M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.